ChemoMetec A/S (CPH:CHEMM)
Denmark · Delayed Price · Currency is DKK 465.60
+2.40 (0.52%)
Aug 17, 2026, 4:59 PM CET
ChemoMetec Market Cap
ChemoMetec has a market cap or net worth of 8.1 billion as of August 17, 2026. Its market cap has decreased by -7.07% in one year.
Market Cap
8.10B
Enterprise Value
7.83B
Revenue
493.12M
Ranking
n/a
PE Ratio
45.78
Stock Price
465.60
ChartMarket Cap Chart
Since December 18, 2006, ChemoMetec's market cap has increased from 374.48M to 8.10B, an increase of 2,063.67%. That is a compound annual growth rate of 16.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 8.10B | -32.28% |
| Dec 30, 2025 | 11.96B | 41.40% |
| Dec 30, 2024 | 8.46B | 25.31% |
| Dec 29, 2023 | 6.75B | -43.81% |
| Dec 30, 2022 | 12.02B | -17.11% |
| Dec 30, 2021 | 14.50B | 44.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.30T |
| Genmab | 121.01B |
| Coloplast | 96.44B |
| Demant | 62.72B |
| H. Lundbeck | 40.85B |
| Zealand Pharma | 22.27B |
| Ambu A/S | 20.20B |
| GN Store Nord | 14.89B |